Fresenius Medical Care AG (FMS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit TTM

0 2B 4B 6B Q4 '08: 3.6B Q1 '09: 3.6B Q2 '09: 3.6B Q3 '09: 3.7B Q4 '09: 3.8B Q1 '10: 3.9B Q2 '10: 4B Q3 '10: 4.1B Q4 '10: 3.8B Q1 '11: 3.8B Q2 '11: 3.8B Q3 '11: 3.8B Q4 '11: 4.2B Q1 '12: 4.3B Q2 '12: 4.4B Q3 '12: 4.4B Q4 '12: 4.6B Q1 '13: 4.6B Q2 '13: 4.7B Q3 '13: 4.7B Q4 '13: 4.7B Q1 '14: 4.7B Q2 '14: 4.8B Q3 '14: 4.9B Q4 '14: 5B Q1 '15: 5.1B Q2 '15: 5.2B Q3 '15: 5.3B Q4 '15: 5.3B Q1 '16: 5.5B Q2 '16: 5.6B Q3 '16: 5.7B Q4 '16: 5.8B Q2 '09 Q3 '10 Q4 '11 Q1 '13 Q2 '14 Q3 '15 Q4 '16

Operating Income TTM

0 900M 1.8B 2.7B Q4 '08: 1.7B Q1 '09: 1.7B Q2 '09: 1.7B Q3 '09: 1.7B Q4 '09: 1.8B Q1 '10: 1.8B Q2 '10: 1.8B Q3 '10: 1.9B Q4 '10: 1.9B Q1 '11: 1.9B Q2 '11: 2B Q3 '11: 2B Q4 '11: 2.1B Q1 '12: 2.1B Q2 '12: 2.2B Q3 '12: 2.2B Q4 '12: 2.2B Q1 '13: 2.2B Q2 '13: 2.2B Q3 '13: 2.2B Q4 '13: 2.3B Q1 '14: 2.2B Q2 '14: 2.2B Q3 '14: 2.3B Q4 '14: 2.3B Q1 '15: 2.3B Q2 '15: 2.3B Q3 '15: 2.3B Q4 '15: 2.3B Q1 '16: 2.4B Q2 '16: 2.5B Q3 '16: 2.5B Q4 '16: 2.6B Q2 '09 Q3 '10 Q4 '11 Q1 '13 Q2 '14 Q3 '15 Q4 '16

Net Income TTM

0 500M 1B 1.5B Q4 '08: 817.6M Q1 '09: 829.8M Q2 '09: 839.9M Q3 '09: 858.8M Q4 '09: 891.1M Q1 '10: 904.1M Q2 '10: 931.3M Q3 '10: 953.8M Q4 '10: 978.5M Q1 '11: 988.1M Q2 '11: 1B Q3 '11: 1B Q4 '11: 1.1B Q1 '12: 1.2B Q2 '12: 1.2B Q3 '12: 1.2B Q4 '12: 1.2B Q1 '13: 1B Q2 '13: 1B Q3 '13: 1B Q4 '13: 1.1B Q1 '14: 1.1B Q2 '14: 1.1B Q3 '14: 1.1B Q4 '14: 1B Q1 '15: 1B Q2 '15: 1.1B Q3 '15: 1B Q4 '15: 1B Q1 '16: 1B Q2 '16: 1.1B Q3 '16: 1.2B Q4 '16: 1.2B Q2 '09 Q3 '10 Q4 '11 Q1 '13 Q2 '14 Q3 '15 Q4 '16

Cost of Revenue TTM

0 5B 10B 15B Q4 '08: 7B Q1 '09: 7B Q2 '09: 7.1B Q3 '09: 7.2B Q4 '09: 7.4B Q1 '10: 7.6B Q2 '10: 7.7B Q3 '10: 7.8B Q4 '10: 8B Q1 '11: 8.1B Q2 '11: 8.3B Q3 '11: 8.4B Q4 '11: 8.4B Q1 '12: 8.6B Q2 '12: 8.8B Q3 '12: 8.9B Q4 '12: 9.2B Q1 '13: 9.4B Q2 '13: 9.5B Q3 '13: 9.7B Q4 '13: 9.9B Q1 '14: 10B Q2 '14: 10.2B Q3 '14: 10.5B Q4 '14: 10.8B Q1 '15: 11.1B Q2 '15: 11.4B Q3 '15: 11.4B Q4 '15: 11.4B Q1 '16: 11.5B Q2 '16: 11.6B Q3 '16: 11.9B Q4 '16: 12.1B Q2 '09 Q3 '10 Q4 '11 Q1 '13 Q2 '14 Q3 '15 Q4 '16

Operating Cash Flow TTM

0 900M 1.8B 2.7B Q2 '09: 1.1B Q3 '09: 1.2B Q4 '09: 1.3B Q1 '10: 1.5B Q2 '10: 1.5B Q3 '10: 1.5B Q4 '10: 1.4B Q1 '11: 1.2B Q2 '11: 1.2B Q3 '11: 1.3B Q4 '11: 1.4B Q1 '12: 1.8B Q2 '12: 1.9B Q3 '12: 2B Q4 '12: 2B Q1 '13: 1.9B Q2 '13: 1.9B Q3 '13: 2B Q4 '13: 2B Q1 '14: 1.8B Q2 '14: 1.8B Q3 '14: 1.9B Q4 '14: 1.9B Q1 '15: 2.6B Q2 '15: 2.1B Q3 '15: 2B Q4 '15: 2B Q1 '16: 1.3B Q2 '16: 2B Q3 '16: 1.8B Q4 '16: 2.1B Q4 '09 Q4 '10 Q4 '11 Q4 '12 Q4 '13 Q4 '14 Q4 '15 Q4 '16

Free Cash Flow TTM

-800M 0 800M 1.6B 2.4B Q2 '09: 454.7M Q3 '09: 597.5M Q4 '09: 765M Q1 '10: 964.7M Q2 '10: 998.4M Q3 '10: 960M Q4 '10: 844.5M Q1 '11: 659.4M Q2 '11: 675.8M Q3 '11: 720.5M Q4 '11: 848.6M Q1 '12: 1.1B Q2 '12: 1.3B Q3 '12: 1.3B Q4 '12: 1.4B Q1 '13: 1.2B Q2 '13: 1.2B Q3 '13: 1.3B Q4 '13: 1.3B Q1 '14: 1B Q2 '14: 922.3M Q3 '14: 1.5B Q4 '14: 929.8M Q1 '15: 2.3B Q2 '15: 1.2B Q3 '15: -226.1M Q4 '15: 1B Q1 '16: 186.9M Q2 '16: 943.8M Q3 '16: 791.4M Q4 '16: 1.1B Q4 '09 Q4 '10 Q4 '11 Q4 '12 Q4 '13 Q4 '14 Q4 '15 Q4 '16

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q3 '09: 294.4M Q1 '10: 297.1M Q2 '10: 297.9M Q3 '10: 298.6M Q1 '11: 300.2M Q2 '11: 300.9M Q3 '11: 301.2M Q1 '12: 302.6M Q2 '12: 302.8M Q3 '12: 303.5M Q1 '13: 303.9M Q2 '13: 301.8M Q3 '13: 301.8M Q1 '14: 301.9M Q2 '14: 302.4M Q3 '14: 303.3M Q1 '15: 305.3M Q2 '15: 305.3M Q3 '15: 305.2M Q1 '16: 305.6M Q2 '16: 305.8M Q3 '16: 306.5M Q1 '17: 306.5M Q2 '17: 306.5M Q3 '17: 306.6M Q1 '18: 306.5M Q2 '18: 306.4M Q3 '18: 306.5M Q1 '19: 306.7M Q2 '19: 303.5M Q3 '19: 301.4M Q1 '20: 297.8M Q2 '20: 292.7M Q3 '20: 292.8M Q1 '21: 292.9M Q2 '21: 292.9M Q3 '21: 293M Q1 '22: 293M Q2 '22: 293.1M Q3 '22: 293.4M Q1 '23: 293.4M Q2 '23: 293.4M Q3 '23: 293.4M Q1 '24: 293.4M Q2 '24: 293.4M Q3 '24: 293.4M Q1 '25: 293.4M Q2 '25: 293.4M Q3 '25: 292.1M Q3 '11 Q1 '14 Q2 '16 Q3 '18 Q1 '21 Q2 '23 Q3 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q4 '08: 2.74 Q1 '09: 2.77 Q2 '09: 2.80 Q3 '09: 2.87 Q4 '09: 2.99 Q1 '10: 3.03 Q2 '10: 3.11 Q3 '10: 3.17 Q4 '10: 3.23 Q1 '11: 3.26 Q2 '11: 3.30 Q3 '11: 3.40 Q4 '11: 3.52 Q1 '12: 4.00 Q2 '12: 4.08 Q3 '12: 4.04 Q4 '12: 3.87 Q1 '13: 3.40 Q2 '13: 3.32 Q3 '13: 3.35 Q4 '13: 3.66 Q1 '14: 3.60 Q2 '14: 3.51 Q3 '14: 3.49 Q4 '14: 3.44 Q1 '15: 3.45 Q2 '15: 3.47 Q3 '15: 3.44 Q4 '15: 3.38 Q1 '16: 3.44 Q1 '09 Q1 '10 Q1 '11 Q1 '12 Q1 '13 Q1 '14 Q1 '15 Q1 '16

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.